Abstract:BackgroundPterygium is an ocular surface disease that can cause visual impairment if it progressively invades the cornea. Although many pieces of research showed ultraviolet radiation is a trigger of pterygium pathological progress, the underlying mechanism in pterygium remains indistinct. MethodsIn this study, we used microarray to evaluate the changes of transcripts between primary pterygium and adjacent normal conjunctiva samples in China. Then, we performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses. Moreover, we constructed protein-protein interaction (PPI) and miRNA-mRNA regulatory networks to predict possible regulatory relationships. We next performed gene set enrichment analysis (GSEA) to explore the similarities and differences of transcripts between Asian studies from the Gene Expression Omnibus database. Furthermore, we took the intersection of differentially expressed genes (DEGs) with other data and identified hub genes of the development of pterygium. Finally, we utilized real-time quantitative PCR to verify the expression levels of candidate genes. ResultsA total of 49 DEGs were identified. The enrichment analyses of DEGs showed that pathways such as the Wnt-signaling pathway and metabolism-related pathways were upregulated, while pathways such as hormone-related and transcription factor-associated pathways were downregulated. The PPI and miRNA-mRNA regulatory networks provide ideas for future research directions. The GSEA of selecting Asian data revealed that epithelial-mesenchymal transition and myogenesis existed in the pathology of pterygium in the Asian group. Furthermore, five gene sets (interferon-gamma response, Wnt beta-catenin signaling, oxidative phosphorylation, DNA repair, and MYC targets v2) were found only in our Chinese datasets. After taking an intersection between selecting datasets, we identified two upregulated (SPP1 and MYH11) and five downregulated (ATF3, FOS, EGR1, FOSB, and NR4A2) hub genes. We finally chose night genes to verify their expression levels, including the other two genes (SFRP2 and SFRP4) involved in Wnt signaling; Their expression levels were significantly different between pterygium and conjunctiva. ConclusionsWe consider hormone-related, metabolic, and Wnt signaling pathways may be important in the pathology of pterygium development. Nine candidate genes we identified deserve further study and can be potential therapeutic targets.

Overexpression of Low-Density Lipoprotein Receptors Stimulated by Vascular Endothelial Growth Factor in Fibroblasts from Pterygium

Targeted delivery of mitomycin C-loaded and LDL-conjugated mesoporous silica nanoparticles for inhibiting the proliferation of pterygium subconjunctival fibroblasts

Impairment of Autophagy Promotes Human Conjunctival Fibrosis and Pterygium Occurrence Via Enhancing the SQSTM1–NF-κB Signaling Pathway

Decreased Pigment Epithelium-Derived Factor and Increased Vascular Endothelial Growth Factor Levels in Pterygia.

Elevated KDM4D Expression in Pterygium: Impact and Potential Inhibition by Lycium Barbarum Polysaccharide

RhoA/ROCK Signaling Regulates TGF-beta 1-Induced Fibrotic Effects in Human Pterygium Fibroblasts through MRTF-A

The Key Role of VEGF in the Cross Talk Between Pterygium and Dry Eye and Its Clinical Significance

EphrinB2 and EphB4 Expression in Pterygia: New Insights and Preliminary Results.

Expression profiling suggests the involvement of hormone-related, metabolic, and Wnt signaling pathways in pterygium progression

Single-cell RNA sequencing reveals the complex cellular niche of pterygium

Expression and Clinical Signiifcance of Cox-2, VEGF in Pterygium

Efficacy of epidermal growth factor in suppressing inflammation and proliferation in pterygial fibroblasts through interactions with microenvironmental M1 macrophages

Expression and function of HGF and C-MET receptor in pterygium

Ephb4 Expression In Pterygium Is Associated With Microvessel Density

Therapeutic effects of two surgery methods on pterygium

Evaluation of global differential gene and protein expression in primary Pterygium: S100A8 and S100A9 as possible drivers of a signaling network

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor

[The Relation Between Expression of Basic Fibroblast Growth Factor and Mast Cells in Pterygium].

Low Rate of Postoperative Pterygium Recurrence in Patients under Treatment with Low-Dose Oral Doxycycline for Chronic Blepharitis: A First Report

Eyes on the Lid: The Impact of Fibroblast Growth Factor Receptor Targeting Drug on Human Meibomian Gland

Lymphatic Microvessel Density As a Predictive Marker for the Recurrence Time of Pterygium: A Three-Year Follow-Up Study